T1	Participants 142 195	patients with the acquired immunodeficiency syndrome.
T2	Participants 551 722	310 adults with AIDS who had recently recovered from an initial episode of PCP and had no treatment-limiting toxic effects of trimethoprim-sulfamethoxazole or pentamidine.
T3	Participants 2124 2171	patients with AIDS who are receiving zidovudine
